Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NVS

Novartis

$86.34

3.78 (4.58%)

, TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

17:48
06/22/17
06/22
17:48
06/22/17
17:48
Hot Stocks
Novartis: FDA approves Tafinlar-Mekinist combo in non-small cell lung cancer »

Novartis (NVS) announced…

NVS

Novartis

$86.34

3.78 (4.58%)

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

, LH

LabCorp

$150.34

4.13 (2.82%)

17:34
06/22/17
06/22
17:34
06/22/17
17:34
Hot Stocks
Thermo Fisher says FDA grants premarket approval for Oncomine Dx Target Test »

Thermo Fisher (TMO)…

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

LH

LabCorp

$150.34

4.13 (2.82%)

NEO

NeoGenomics

$8.70

0.21 (2.47%)

CGIX

Cancer Genetics

NVS

Novartis

$86.34

3.78 (4.58%)

PFE

Pfizer

$34.06

0.18 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 11

    Jul

  • 12

    Jul

  • 02

    Aug

  • 27

    Aug

PRXL

Parexel

$87.11

-0.14 (-0.16%)

17:29
06/22/17
06/22
17:29
06/22/17
17:29
Hot Stocks
Breaking Hot Stocks news story on Parexel »

Starboard liquidates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

TEVA

Teva

$32.52

1.47 (4.73%)

17:15
06/22/17
06/22
17:15
06/22/17
17:15
Conference/Events
Teva management to meet with Maxim »

Institutional dinner to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 30

    Aug

PFE

Pfizer

$34.06

0.18 (0.53%)

, AMGN

Amgen

$173.82

2.47 (1.44%)

16:52
06/22/17
06/22
16:52
06/22/17
16:52
Hot Stocks
Pfizer receives complete response letter for epoetin alfa biosimilar »

Pfizer (PFE) announced it…

PFE

Pfizer

$34.06

0.18 (0.53%)

AMGN

Amgen

$173.82

2.47 (1.44%)

JNJ

Johnson & Johnson

$136.05

1.14 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

  • 13

    Jul

  • 18

    Jul

  • 19

    Jul

  • 02

    Aug

  • 14

    Aug

  • 27

    Aug

  • 03

    Feb

GSK

GlaxoSmithKline

$44.35

0.725 (1.66%)

15:35
06/22/17
06/22
15:35
06/22/17
15:35
Periodicals
GlaxoSmithKline pursuing sale of MaxiNutrition unit, Sky News says »

GlaxoSmithKline's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$35.50

0.62 (1.78%)

13:45
06/22/17
06/22
13:45
06/22/17
13:45
Options
AstraZeneca call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NVS

Novartis

$86.56

3.995 (4.84%)

12:59
06/22/17
06/22
12:59
06/22/17
12:59
Upgrade
Novartis rating change at Barclays »

Novartis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

MDT

Medtronic

$89.28

0.49 (0.55%)

12:50
06/22/17
06/22
12:50
06/22/17
12:50
Hot Stocks
Medtronic reports order delays due to temporary IT infrastructure issue »

Medtronic, in a statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

ABBV

AbbVie

$72.80

1.455 (2.04%)

11:44
06/22/17
06/22
11:44
06/22/17
11:44
Upgrade
AbbVie rating change at Societe Generale »

AbbVie upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.